Richard M Cabot, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 165 Poplar St, Suite 2, Millinocket, ME 04462 Phone: 207-723-3003 Fax: 207-723-3006 |
Jason F Campbell, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 165 Poplar St, Suite 2, Millinocket, ME 04462 Phone: 207-723-3003 Fax: 207-723-3006 |
Mark A Kowalski, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 165 Poplar St, Suite 2, Millinocket, ME 04462 Phone: 207-723-3003 Fax: 207-723-3006 |
News Archive
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
In a biological quirk that promises to provide researchers with a new approach for studying and potentially treating Fragile X syndrome, scientists at the University of Massachusetts Medical School (UMMS) have shown that knocking out a gene important for messenger RNA (mRNA) translation in neurons restores memory deficits and reduces behavioral symptoms in a mouse model of a prevalent human neurological disease.
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne.
In a study of specially designed peripheral prism glasses for hemianopia patients (blinded in half the visual field in both eyes), scientists found that two-thirds of patients continued to wear the glasses at the end of the study period and beyond, indicating a high level of success.
› Verified 9 days ago